Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. - Wikidata - awgldk - TriplyDB

Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.

Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.

http://www.wikidata.org/entity/Q33397195

about

Treatment of inflammatory myopathy: emerging therapies and therapeutic targets HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population Morbidity and mortality in adult polymyositis and dermatomyositis.Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in asian population.Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample survey Inflammatory myopathies: One-center experience.Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.Multiple values of (18)F-FDG PET/CT in idiopathic inflammatory myopathy.Update on the pharmacological treatment of adult myositis.Pharmacological management of dermatomyositis.Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study.Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.Use of rituximab in histologically confirmed idiopathic inflammatory myositis: a case series.Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease.Recent developments on treatment strategies and the prognosis of dermatomyositis: a review.The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India.Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.

P2860

Q26796546-4C82196A-45D8-4F05-8C8C-C30F763C49DC Q33772990-75F7E381-0841-409F-96CA-95A246263C47 Q34260708-F9A3C5DC-6DB3-4312-AAED-A23641CC3B9F Q35999248-5B06761F-2BEB-40FC-A9E0-AB37F701435C Q36692379-2D42C4A0-85C0-40F7-91AF-C8A194896B1A Q36844843-A2809E21-74EC-4E5E-84A2-9BB4E3C6FA2C Q36903269-A81FDD91-DB49-4958-B08D-0FDE556D6BB8 Q37296359-30E1BD7B-894A-45F3-9ED9-B4BB1F298C0A Q37690885-93F2D30D-3545-434E-B77B-BCA3626551F4 Q38613068-175FF301-3941-4682-8A5A-16F734E35CAD Q38813275-68C53B30-D596-46F7-8531-FB3B57F5C4A9 Q39425296-E086C340-CEC7-4A5F-8445-665116CBB853 Q40263745-9575E63C-4B82-4311-998D-577BC4250464 Q40742414-4BF69A03-6B85-40F8-B4A3-30EA739F7D68 Q44862147-CA7DF02C-2035-47D0-AC30-D5CE74090C60 Q46758099-66A88461-4F24-42C7-8162-C6E330B93845 Q47160515-3FAF3546-F4E5-4D8E-9B1E-0290B38CDDE7 Q47436112-B5CF6619-47F6-4E4C-BAA1-988760ACCD9A Q47659489-A372A25E-C1CB-4D30-A87A-9E02D049113E Q50654020-84821913-E52B-473D-8DFA-E66650553697 Q55255767-4A27BFE9-5ADC-4AFA-8B0F-2F56817C33FC

P2860

Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.

http://www.wikidata.org/entity/Q33397195

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Survival analysis of patients ...... analysis of 192 Chinese cases.

@ast

Survival analysis of patients ...... analysis of 192 Chinese cases.

@en

type

label

Survival analysis of patients ...... analysis of 192 Chinese cases.

@ast

Survival analysis of patients ...... analysis of 192 Chinese cases.

@en

prefLabel

Survival analysis of patients ...... analysis of 192 Chinese cases.

@ast

Survival analysis of patients ...... analysis of 192 Chinese cases.

@en

P1433

Q33397195-1FDCC55E-5E25-469D-B76D-1713A860F7A8

P1476

Q33397195-6968391B-B355-49B3-A68F-84BAA35F35DF

P2093

Q33397195-273F9561-257A-4FCB-8FDB-4DAC9319C3B1

Q33397195-651E2C57-7D2C-49A2-82B8-0F1E376EC62E

Q33397195-65ED3157-0D3F-4F91-B5D8-1B4D165B0143

Q33397195-7C6F7E67-6928-4AE2-8193-67FEA86599CB

Q33397195-9BD521D8-3B84-4FDD-BE95-31F64434C206

Q33397195-A93F1E03-5580-40EA-8256-8CA22DF93CC6

Q33397195-ACC4C9C9-24E7-44E0-B549-B7D19CC5C43E

Q33397195-F620071B-5803-421A-94F9-CFFAE21BECD5

P2860

Q33397195-0021EB0F-521F-4B83-B16E-777D37283368

Q33397195-0E414F90-71BE-46BD-87B9-118E4B1D6883

Q33397195-22379FA3-31B1-406E-96E5-903410D7EF67

Q33397195-33C107C0-A230-4953-9A4F-C5992B88CD59

Q33397195-3D125640-9C2C-40DF-89EC-E904BC713322

Q33397195-3D8874D3-EC20-468D-B88C-31E6CBD3F251

Q33397195-4E270D68-92F1-402C-8CE3-687A014311F3

Q33397195-5675DA06-3BEB-4E45-9D75-D38A8916CBF6

Q33397195-5CB2A2F8-4E75-4EEC-8829-0E51B4F9605A

Q33397195-5CF33883-4F45-4053-A3C6-9D26FEDCFCE1

P304

Q33397195-E917EE4C-333F-483E-A9B4-7838AB968E44

P31

Q33397195-633FCB9D-0471-4D5A-BD30-530616363FBB

P356

Q33397195-6FBC0103-9341-4DCC-8891-E6F336B5B31A

P433

Q33397195-E6DA12D2-E23D-4C4A-8BBD-B9C1EA427B3D

P478

Q33397195-8956032A-2884-4E50-9F6C-232673BBBD11

P50

Q33397195-81F07099-405C-4851-B76E-6EC83912FF47

P577

Q33397195-82B54AFA-D96F-4833-9BAC-205BE11B878B

P698

Q33397195-2ACC1E21-50C2-4764-96FE-BC6927479519

P921

Q33397195-362151E9-6C8A-484C-9927-83B6DEF1BF9D

Q33397195-690A51A3-0B03-4C5D-8C6A-176660C957FD

P356

S10067-011-1840-0

P1433

Clinical Rheumatology

P1476

Survival analysis of patients ...... analysis of 192 Chinese cases.

@en

P2093

Chang-Fu Kuo

http://www.w3.org/2001/XMLSchema#string

Hsiao-Chun Chang

http://www.w3.org/2001/XMLSchema#string

Huei-Huang Ho

http://www.w3.org/2001/XMLSchema#string

I-Jung Chen

http://www.w3.org/2001/XMLSchema#string

Kuang-Hui Yu

http://www.w3.org/2001/XMLSchema#string

Shue-Fen Luo

http://www.w3.org/2001/XMLSchema#string

Yeong-Jian Jan Wu

http://www.w3.org/2001/XMLSchema#string

Yu-Ming Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Polymyositis and dermatomyositis (first of two parts).

Current approach to the treatment of polymyositis and dermatomyositis.

Interstitial lung disease in polymyositis and dermatomyositis.

Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

Long-term outcome in polymyositis and dermatomyositis.

Malignancy in the setting of the anti-synthetase syndrome.

Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA.

Polymyositis-dermatomyositis-associated interstitial lung disease.

P304

1595-1601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-011-1840-0

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21915609

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis